However, in the study by Chakiryan et al., they analyzed the association between common somatic mutations in ccRCC and the tumor microenvironment, and they found that SETD2 mutations were associated with significantly reduced levels of FoxP3+ T cells in tumors, stroma, and the tumor–stroma interface [48]. The gene discussed is SETD2; the disease is neoplasm.